These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28192715)

  • 1. Rivaroxaban shows promise as effective therapy for cancer patients with venous thromboembolic disease.
    Theberge I; Bowdridge J; Forgie MA; Carrier M; Louzada M; Siquiera L; Rhodes M; Wells PS
    Thromb Res; 2017 Apr; 152():4-6. PubMed ID: 28192715
    [No Abstract]   [Full Text] [Related]  

  • 2. Low molecular weight heparin versus rivaroxaban in the treatment of venous thromboembolism in gastrointestinal malignancies.
    Choe HK; De Sancho MT; Kim SS; Dai T; Shah MA
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):227-230. PubMed ID: 29389673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism.
    Krause M; Henningsen A; Torge A; Juhl D; Junker R; Kenet G; Kowalski D; Limperger V; Mesters R; Anonymous ; Rocke A; Shneyder M; Clausnizer H; Schiesewitz H; Nowak-Göttl U
    Thromb Res; 2016 Dec; 148():145-151. PubMed ID: 27687905
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical management of rivaroxaban for the treatment of venous thromboembolism.
    Imberti D; Benedetti R
    Clin Appl Thromb Hemost; 2015 May; 21(4):309-18. PubMed ID: 24057396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rivaroxaban starter packs on emergency department throughput.
    Ayers GT; D'Amico PhD F; Farrah RM; Klatt PM; Baumgartner MA
    Am J Emerg Med; 2018 Sep; 36(9):1698-1699. PubMed ID: 29429797
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.
    Arachchillage D; Reynolds R; Devey T; Maclean R; Kitchen S; van Veen JJ
    Thromb Res; 2016 Nov; 147():32-35. PubMed ID: 27669125
    [No Abstract]   [Full Text] [Related]  

  • 7. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism.
    Sciascia S; Breen K; Hunt BJ
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):476-7. PubMed ID: 25923780
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of venous thromboembolism in a 22-year-old woman taking an oral contraceptive pill.
    Shafran DM; Wu C
    CMAJ; 2017 Nov; 189(47):E1459-E1460. PubMed ID: 29180385
    [No Abstract]   [Full Text] [Related]  

  • 9. [The EINSTEIN CHOICE study].
    Agnelli G; Becattini C; Giustozzi M; Imberti D; Benedetti R; Fontana M
    G Ital Cardiol (Rome); 2017 Sep; 18(9):613-617. PubMed ID: 28845870
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.
    Prandoni P; Lensing AWA; Prins MH; Gebel M; Pap AF; Homering M; Bauersachs R; Beyer-Westendorf J; Bounameaux H; Cohen AT; Davidson BL; van Bellen B; Verhamme P; Wells PS; Yuan Z; Levitan B; Weitz JI
    Thromb Res; 2018 Aug; 168():121-129. PubMed ID: 30064683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients.
    Ten Cate H; Lensing AWA; Weitz JI; Middeldorp S; Beyer-Westendorf J; Kubitza D; Brighton T; Raskob GE; Mismetti P; Prandoni P; Gebel M; Prins MH
    Thromb Res; 2018 Oct; 170():75-83. PubMed ID: 30121419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Oral Factor Xa Inhibitor for Venous Thromboembolism in a Patient with Antithrombin Deficiency.
    Minami K; Kumagai K; Sugai Y; Nakamura K; Naito S; Oshima S
    Intern Med; 2018 Jul; 57(14):2025-2028. PubMed ID: 29526957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.
    Platton S; Bowles L; MacCallum P
    Br J Haematol; 2017 Nov; 179(3):511-513. PubMed ID: 27392166
    [No Abstract]   [Full Text] [Related]  

  • 14. Rivaroxaban for the treatment of venous thromboembolism. A "real-life" perspective in 103 patients.
    Jara-Palomares L; Sanchez-Oro-Gomez R; Elias-Hernandez T; Morillo-Guerrero R; Ferrer-Galvan M; Asensio-Cruz MI; Barrot-Cortes E; Otero-Candelera R
    Thromb Res; 2014 Sep; 134(3):617-21. PubMed ID: 25034320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of rivaroxaban in real-life treatment of venous thromboembolism: results of the TEV Survey, an Italian epidemiological study].
    Pesavento R; Iori I;
    G Ital Cardiol (Rome); 2017 Mar; 18(3):239-246. PubMed ID: 28398382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases.
    Mateos Rodríguez JJ; Bellido D; Castro D; Portillo Sánchez J; Vanegas R; Núñez García A
    Reumatol Clin (Engl Ed); 2019; 15(5):e33-e35. PubMed ID: 28546102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients-a prospective interventional study.
    Takai S; Nakanishi N; Yokota I; Imai K; Yamada A; Kawasaki T; Kasahara T; Okada T; Sawada T; Matoba S
    Sci Rep; 2022 Dec; 12(1):21569. PubMed ID: 36513734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
    Ma G; Zhang R; Wu X; Wang D; Ying K
    Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban for the treatment and prevention of thromboembolic disease.
    Antoniou S
    J Pharm Pharmacol; 2015 Aug; 67(8):1119-32. PubMed ID: 26059702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.